- Home
- BCRX vs NVTS Comparison
BCRX vs NVTS Comparison
Compare BCRX & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- NVTS
- Stock Information
- Founded
- BCRX 1986
- NVTS 2014
- Country
- BCRX United States
- NVTS United States
- Employees
- BCRX N/A
- NVTS N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- NVTS Semiconductors
- Sector
- BCRX Health Care
- NVTS Technology
- Exchange
- BCRX Nasdaq
- NVTS Nasdaq
- Market Cap
- BCRX 1.7B
- NVTS 1.3B
- IPO Year
- BCRX 1994
- NVTS N/A
- Fundamental
- Price
- BCRX $9.19
- NVTS $6.57
- Analyst Decision
- BCRX Buy
- NVTS Strong Buy
- Analyst Count
- BCRX 9
- NVTS 6
- Target Price
- BCRX $16.89
- NVTS $3.79
- AVG Volume (30 Days)
- BCRX 3.6M
- NVTS 59.4M
- Earning Date
- BCRX 08-04-2025
- NVTS 08-04-2025
- Dividend Yield
- BCRX N/A
- NVTS N/A
- EPS Growth
- BCRX N/A
- NVTS N/A
- EPS
- BCRX N/A
- NVTS N/A
- Revenue
- BCRX $503,485,000.00
- NVTS $74,145,000.00
- Revenue This Year
- BCRX $39.04
- NVTS N/A
- Revenue Next Year
- BCRX $13.26
- NVTS $51.14
- P/E Ratio
- BCRX N/A
- NVTS N/A
- Revenue Growth
- BCRX 41.67
- NVTS N/A
- 52 Week Low
- BCRX $6.02
- NVTS $1.52
- 52 Week High
- BCRX $11.31
- NVTS $9.17
- Technical
- Relative Strength Index (RSI)
- BCRX 34.12
- NVTS 55.04
- Support Level
- BCRX $9.19
- NVTS $6.47
- Resistance Level
- BCRX $10.07
- NVTS $7.99
- Average True Range (ATR)
- BCRX 0.34
- NVTS 0.74
- MACD
- BCRX -0.18
- NVTS -0.23
- Stochastic Oscillator
- BCRX 8.10
- NVTS 9.09
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.